Current understanding of systemic lupus erythematosus

Area of Science:

• Rheumatology
• Immunology
• Genetics

Background:

• Systemic lupus erythematosus (SLE) is a significant inflammatory rheumatic disease.
• The exact etiology of SLE remains unknown, with genetic, hormonal, and infective factors suspected.
• SLE shows a familial tendency, with increased frequency in individuals with complement deficiencies.

Purpose of the Study:

• To explore the implicated factors in the etiology of Systemic Lupus Erythematosus (SLE).
• To investigate the role of genetic, hormonal, and infective factors in SLE.
• To examine immunological aberrations, including T-cell function, in SLE patients and their families.

Main Methods:

• Analysis of C4 null allele frequencies in SLE patients and normal individuals.
• Detection of lymphocytotoxic antibodies and viral antigens in SLE patients and contacts.
• Assessment of hormonal influences, including estrogen metabolism and disease exacerbation during the puerperium.
• Evaluation of suppressor T-cell function in active SLE patients and asymptomatic siblings.

Main Results:

• 80% of SLE patients in a UK study had a C4 null allele, versus 20% of controls.
• Viral antigens and lymphocytotoxic antibodies were found in SLE patients and contacts.
• A 9:1 female to male ratio in SLE, rising to 30:1 in childbearing years, suggests hormonal influence.
• Impaired suppressor T-cell function is common in active SLE and present in asymptomatic siblings, particularly females.

Conclusions:

• Genetic factors, such as complement deficiencies (C4 null allele), are strongly associated with SLE.
• While infective agents are investigated, direct evidence in human SLE is lacking.
• Hormonal factors significantly influence SLE, evidenced by gender ratios and puerperium exacerbations.
• Immunological abnormalities, including impaired T-cell function, contribute to SLE pathogenesis.